DISPERMOX Drug Patent Profile
✉ Email this page to a colleague
When do Dispermox patents expire, and when can generic versions of Dispermox launch?
Dispermox is a drug marketed by Ranbaxy Labs Ltd and is included in two NDAs.
The generic ingredient in DISPERMOX is amoxicillin. There are forty-six drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dispermox
A generic version of DISPERMOX was approved as amoxicillin by TEVA on December 22nd, 1992.
Summary for DISPERMOX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 70 |
Clinical Trials: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DISPERMOX at DailyMed |
Recent Clinical Trials for DISPERMOX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Nationwide Children's Hospital | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for DISPERMOX
US Patents and Regulatory Information for DISPERMOX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ranbaxy Labs Ltd | DISPERMOX | amoxicillin | TABLET, FOR SUSPENSION;ORAL | 065080-002 | Aug 11, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ranbaxy Labs Ltd | DISPERMOX | amoxicillin | TABLET, FOR SUSPENSION;ORAL | 065080-001 | Aug 11, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ranbaxy Labs Ltd | DISPERMOX | amoxicillin | TABLET, FOR SUSPENSION;ORAL | 065159-001 | Dec 4, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |